61 results about "Amputated extremity" patented technology

Systems, devices, and methods of the present application can accelerate and reduce medical complications associated with healing of amputation wounds. The devices and methods utilize a compression structure and negative pressure to cause the amputation wound to preferentially close from the deepest portion of the wound to the shallowest portion.

A prosthetic device which couples to the remaining portion of a limb of an amputee which provides a ball handling structure including a ball handling surface which defines an opening through which a ball passes into and out of a ball receiving cavity allowing the ball to be handled by the amputee.

Systems, devices, and methods of the present application can accelerate and reduce medical complications associated with healing of non-planar wounds such as amputation wounds. The devices and methods utilize a collapsing structure and negative pressure to cause the shaped wound to preferentially close. The structure can accommodate movement over curved tissue surfaces, which can utilize scales or interleaved elements to provide efficient wound closure along arcuate paths. This structure can enable gradual closure from the deepest portion of the wound to the shallowest portion.

Valve for a prosthesis socket, the socket delineating an open cavity to receive a stump of an amputated limb and delineating a pass-through hole opening into the cavity and designed to receive the valve, the valve including a support in which a pass-through channel is formed and an element movable between an outlet position in which the element allow an air flow out of the channel in an outlet direction and a sealing position in which the element prevent any air flow inside the channel in an opposite direction to the outlet direction, the support including a thread configured to mount the support in removable manner inside the pass-through hole, and to enable disassembly of the support in an opposite direction to the outlet direction.

A method of amputating and morcellating a uterus (10) includes introducing a first tissue bag (1) into the abdomen of the patient, and placing the first tissue bag over the uterus. A laparoscopic surgical instrument (11) is introduced into the first tissue bag, and the uterus (10) is amputated using the laparoscopic surgical instrument. The first tissue bag (1) is closed around the amputated uterus, and the first tissue bag containing the amputated uterus is placed into a second tissue bag (20). A morcellating instrument is introduced into the second tissue bag (20) and the uterus is morcellated within the second tissue bag. Once the uterus (10) has been morcellated, the second tissue bag (20) containing the morcellated uterus is removed from the abdomen of the patient.

A prosthetic suspension-mounting system which employs an improved flathead bolt and socket centering cup combination for securement of an amputee-limb enveloping liner within a prosthesis. The liner has a strap fixedly attached on the bottom end of the liner by a flathead bolt. The mounting system also includes a containment socket for seating the liner in the prosthesis using the head of the flathead bolt as a bearing surface against a floor of the socket. The containment socket has a slot there through at a position corresponding to the strap of the liner. The socket is provided with a disk-shaped recess having a flat floor, and the liner is provided with a distal flathead bolt having a flat head to provide a direct bearing surface against the floor of the socket. This provides a delimited bearing surface to keep the liner substantially centered within the prosthesis while still affording a lateral degree of freedom to avoid concentration of lateral forces.

The present disclosure is related to a method of managing diabetic foot ulcers (DFUs), pressure ulcers, venous leg ulcers and associated complications such as bacterial infection, gangrene, tissue necrosis, amputation, proximal limb loss and septicaemia. This method of managing is by administration of pharmaceutical composition comprising pentameric type A procyanidin, trimeric procyanidin and tetrameric procyanidin, optionally along with pharmaceutically acceptable excipient.

A device and method for umbilicus protection during abdominal surgery; and, especially plastic reconstructive and aesthetic surgery requiring umbilicoplasty and / or umbilicus transposition is provided. The device embodies an umbilicus shield, which envelops the umbilical pedicle during abdominal surgery. The device can include a tubular element, having a distal end and a proximal end, containing near its proximal end, means for releasabley retaining suture material from tacking stitches taken in the umbilicus to provide means for drawing the umbilical pedicle into the tubular element. The suture material is advantageously drawn through the tubular element by means of a suture shuttle which contains, proximate its distal end, means for releasabley retaining the suture material. The device facilitates umbilicoplasty and umbilicus transposition during abdominal surgery; prevents nicks or cuts during circum umbilicus dissection; prevents nicks, cuts, or amputation of the umbilicus during defattening; and, reduces the possibility of umbilical pedicle strangulation during rectus abdominis musculoaponeurotic plication. The method prevents such strangulation and assures proper positioning of the orifice and umbilicus during umbilicus transpositions.

A limb prosthesis which via coupling means is adapted to be connected to an implant in the form of an osseointegrated shaft projecting from an amputated stump. The coupling means comprises a flexible joint and the prosthesis further comprises at least one force transmitting device secured to and extending from a prosthetic member connected to the coupling means up to a position on the amputated stump or body portion to which the stump connects. The force transmitting device is adapted to be secured to the stump or other body portion in such a way that it relieves the implant from at least part of the bending and / or rotational forces exerted to the prosthetic member.

A hinged connecting device comprising a damping mechanism intended to counter a predetermined resistance at least during bending of the prosthesis (1), by replacing the muscle groups usually used for this purpose. The damping mechanism (200) is capable of being switched between a first operating mode (M1), selected by default, in which the value of the resistance corresponds to a first maximum value (Vmax), and a second operating mode (M2), that can be actuated only in a hyperextension position (P0) of the prosthesis (1), in which the resistance value corresponds to a second minimum value (Vmin); and the hinged connecting device (2) moreover comprises a fully mechanical locking system (3), arranged in order to allow the second operating mode (M2) to be activated only when the inclination of the tibial part (102) exceeds a first predetermined oriented angle (X1) relative to the vertical.

The invention relates to a prosthesis shaft for receiving an amputation stump of an extremity, comprising connecting means for a distal prosthesis device (2), wherein the prosthesis shaft (1) comprises at least one shell (11, 12), which has an arched, open cross-section and the shell ends of which in the applied state overlap each other at least partially, at least one tensioning means (14, 15) being disposed on the shell (11, 12), said means acting in the circumferential direction and tensioning the shell ends relative to each other, and the shell (11, 12) being made of a dimensionally stable plastic having regions with varying elasticity.

The invention discloses a compound cell preparation, a preparation method and application of the preparation. The preparation comprises autologous platelet rich plasma (PRP), autologous adipose derived stromal cells (ADSCs) and endothelial progenitor cells (EPCs) of ADSC sources. The preparation method comprises the following steps that fat is collected, and adipocyte is separated; the adipocyte is cultured through an ADSC culture medium to obtain P2-generation autologous ADSCs; the P2-generation autologous ADSCs are cultured through an EPC culture medium to obtain EPCs of P0-generation ADSC sources; anticoagulation peripheral blood of a receptor is collected and centrifuged to obtain PRP, and the application of the compound cell preparation in the medicine for treating lower extremity arteriosclerosis obliterans due to diabetes is achieved. The compound cell preparation has the advantages that the EPC culture medium is adopted for inducing the ADSCs to be cultured, the EPCs with the expression percentage of CD133 as 68.72+ / -11.60% and the expression percentage of vWF as 75.91+ / -9.83% are obtained, bone marrow or mobilized peripheral blood does not need to be collected, and after affected parts of patients with lower extremity arteriosclerosis obliterans due to diabetes are injected with the preparation, the limb pain feeling and cold feeling can be lowered, and the new generation rate of collateral vessels is 100%; the total survival rate is 78.12%, the limb salvage survival rate is 68.00%, and the survival life of artificial limbs of the patients can be effectively prolonged.

The invention relates to the technical field of medical instruments, and concretely relates to a lower limb blood supply condition monitoring device. The device comprises a monitor, a first monitoringunit and a second monitoring unit, and the first monitoring unit and the second monitoring unit are electrically connected with the monitor. The problem that the change of artery ischemia of the lower limb cannot be well reflected due to large subjective feeling individual differences of medical staff can be effectively solved, the skin temperature and color of the affected limb and the arterialpulse change can be monitored in real time, and when the skin temperature and color of the affected limb and the arterial pulse change are monitored to be abnormal, an alarm sound is sent out immediately to remind the medical staff to treat the patient to avoid the patient from missing the optimal treatment opportunity, so the adverse phenomenon of ischemic necrosis of limbs of the patient is avoided, the potential safety hazard of amputation of the patient is eradicated, and the life safety of the patient is effectively guaranteed.